Gunzburg named research options for nasal vaccine against COVID-19

There are different options for the study of the nasal vaccine against COVID-19  - both those who have already been vaccinated with Sputnik V and those who do not have antibodies will become participants, said the director of the National Research Center for Epidemiology and Microbiology. Gamalei Alexander Gintsburg. His words are reported by RIA Novosti.

“There are different options for research design. As part of the study, it is planned to vaccinate with a nasal vaccine both those who have already been vaccinated with Sputnik V and those who do not have antibodies, ”the agency quotes Gunzburg.

Earlier, Gunzburg said that the nasal vaccine is the second component of Sputnik V, designed to be sprayed into the nose. The scientist noted that the vaccine against COVID-19 in the form of a nasal spray cannot replace the injectable vaccine, it was created only for additional protection of the body.

In October, the Ministry of Health authorized the use of a nasal form of the vaccine for volunteers during the second phase of testing a new form of the drug. The research will last until December 2023 and will involve 500 volunteers.